KRAS and pancreatic neoplasm: Instead of targeting the upstream and midstream signaling modules, we propose to stop malignant tumor growth of pancreatic cancer cells by targeting the most downstream signal module–the SIAH E3 ligases–in the oncogenic K-RAS signaling pathway [72,134,135] (Figure 1).